These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23217431)

  • 1. Life-saving devices reach the end of life with heart failure.
    Matlock DD; Stevenson LW
    Prog Cardiovasc Dis; 2012; 55(3):274-81. PubMed ID: 23217431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of implantable cardioverter-defibrillators at end of life.
    Pettit SJ; Jackson CE; Gardner RS
    Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical challenges of deactivation of cardiac devices in advanced heart failure.
    Chamsi-Pasha H; Chamsi-Pasha MA; Albar MA
    Curr Heart Fail Rep; 2014 Jun; 11(2):119-25. PubMed ID: 24619521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with ICDs at the end of life (EOL): a qualitative study.
    Kelley AS; Mehta SS; Reid MC
    Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
    Waterhouse E; Ahmad F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
    Herman M; Horner K; Ly J; Vayl Y
    J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients With Heart Failure.
    Brady DR
    Crit Care Nurse; 2016 Dec; 36(6):24-31. PubMed ID: 27908943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardiac defibrillators and end-of-life care--time for reflection, deliberation and debate?
    Sheehan M; Newton PJ; Stobie P; Davidson PM
    Aust Crit Care; 2011 Nov; 24(4):279-84. PubMed ID: 21676627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implantable cardiac device deactivation at the end of life].
    Romanò M; Gorni G
    G Ital Cardiol (Rome); 2020 Apr; 21(4):286-295. PubMed ID: 32202561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-of-life options for patients with advanced heart failure.
    Goldfinger JZ; Adler ED
    Curr Heart Fail Rep; 2010 Sep; 7(3):140-7. PubMed ID: 20585999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magical thinking around end of life: An editorial on 'Implantable Cardioverter Defibrillator deactivation discussions: Reality vs. recommendations'.
    MacKenzie MA
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):8-9. PubMed ID: 26791007
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
    Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
    Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining nonpharmacologic therapies for advanced heart failure: the Münster experience with the assist device-defibrillator combination.
    Deng MC; Tjan TD; Asfour B; Gradaus R; Böcker D; Loick HM; Baba HA; Breithardt G; Scheld HH; Borggrefe M; Hammel D
    Am J Cardiol; 1999 Mar; 83(5B):158D-160D. PubMed ID: 10089859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.
    Refaat MM; Tanaka T; Kormos RL; McNamara D; Teuteberg J; Winowich S; London B; Simon MA
    J Card Fail; 2012 Feb; 18(2):140-5. PubMed ID: 22300782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
    Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
    Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICD deactivation: review of literature and clinical recommendations.
    Thanavaro JL
    Clin Nurs Res; 2013 Feb; 22(1):36-50. PubMed ID: 22645402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex Care Options for Patients With Advanced Heart Failure Approaching End of Life.
    Wordingham SE; McIlvennan CK; Dionne-Odom JN; Swetz KM
    Curr Heart Fail Rep; 2016 Feb; 13(1):20-9. PubMed ID: 26829929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device therapy for heart failure.
    Boehmer JP
    Am J Cardiol; 2003 Mar; 91(6A):53D-59D. PubMed ID: 12670643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.